Cognizant has been recognized as a Leader for the third year in a row in Everest Group’s PEAK Matrix® for Life Sciences Operations 2022. Among 32 global life sciences service vendors, Everest Group highlighted Cognizant’s Life Sciences Operations offering for its vision and strategy, end-to-end capabilities, intelligent automation solutions and global delivery footprint.  

Cognizant was also acknowledged for its proprietary offering, Cognizant Neuro™, an intelligent automation fabric that leverages automation and analytics to infuse medical knowledge within safety case processing. The platform enhances patient safety, delivers deep medical insights for decision-making, and provides superior use experience – enabling resources to progress from case processing to safety surveillance and proactive risk management activities.  

“The life sciences industry is witnessing a paradigm shift in the way it delivers care, including patient-provider interactions, decentralized clinical trials and an increasing emphasis on regulatory compliance,” said Darpan Ahuja, Vice President and Life Sciences Markets Leader, Cognizant. “As Cognizant continues to meet these challenges for our clients, this recognition by Everest Group confirms our strengths, capabilities and commitment to help clients build and run advanced life sciences operations.”

“To capitalize on the growth opportunities in the constantly evolving life sciences market, service providers are investing in enhancing their offerings across the value chain, such as automation and analytics-based solutions,” said Abhishek AK, Practice Director at Everest Group. “Cognizant’s increased focus on pharmacovigilance, clinical trials and commercial services combined with its diversified client portfolio and robust strategy for technology enhancement are driving the company’s importance across the life sciences industry.”

The Cognizant life sciences team provides domain-aligned consulting, technology, and business process solutions globally, serving the world’s top 30 pharmaceutical companies, top 10 biotech companies and 13 of the top 15 medical device companies.

For more information visit here.